This information is effective as of 1 de julio de 2024, and applies to all commercial employer groups that are assigned to the Net Results formulary. All changes to this list are the result of a comprehensive review of relevant clinical information by the Prime Therapeutics National Pharmacy and Therapeutics Committee.
Individual Market (Direct Pay/Direct Pay Exchange) Formulary
This information is effective as of 1 de julio de 2024 and applies to the individual market segment (Direct Pay and Direct Pay Exchange) of BCBSRI products assigned to the Net Results HIM-compliant formulary. These changes do not apply to the BlueCHiP for Medicare programs. Any changes to this list are the result of a comprehensive review of relevant clinical information by the Prime Therapeutics National Pharmacy and Therapeutics Committee, with consultation form the BCBSRI Pharmacy and Therapeutics Committee.